跳至主要内容
临床试验/2022-500816-21-00
2022-500816-21-00撤回4 期

STOP-COPD Standard vs Targeted Oxygen Therapy Prehospital for Chronic Obstructive Pulmonary Disease

Præhospitalet1 个研究点 分布在 1 个国家目标入组 1,888 人开始时间: 2022年9月12日最近更新:

试验速览

阶段
4 期
状态
撤回
发起方
入组人数
1,888
试验地点
1
主要终点
30-day mortality

研究概览

简要总结

To determine whether prehospital titrated oxygen in patients with suspected AECOPD will decrease 30-day mortality compared to patients receiving standard care.

入排标准

年龄范围
18 years 至 65+ years(18-64 Years, 65+ Years)
接受健康志愿者

入选标准

  • Treating EMT or Paramedic suspects acute exacerbation of chronic obstructive pulmonary disease
  • Patients over the age of 40 years

排除标准

  • Non-COPD bronchospasm
  • Known or suspected pregnancy
  • Prehospital NIV, invasive or bag mask assisted ventilation
  • Allergy to inhalation drug (Salbutamol)
  • Transfer between hospitals
  • More than 2 doses (5 mg salbutamol) inhalation drug, given by EMT or paramedic (acute treatment), before allocated treatment is initiated
  • Readmission within 30 days from last randomization

结局指标

主要结局

30-day mortality

30-day mortality

次要结局

  • 24-hour mortality
  • 7-day mortality
  • Length of hospitalization
  • ICU admission rate
  • Length of ICU admission
  • In-hospital need for non-invasive ventilation
  • Time to non-invasive ventilation
  • In-hospital need for invasive ventilation
  • Time to invasive ventilation
  • Proportion of patients with respiratory acidosis on arrival to hospital
  • The degree of acidosis based on the pH-value
  • Patient experienced dyspnoea on a verbal rating scale 0-10
  • Readmission rate

研究者

发起方
Præhospitalet
申办方类型
Hospital/Clinic/Other health care facility
责任方
Principal Investigator
主要研究者

Martin Fauerholt Gude

Scientific

Præhospitalet

研究点 (1)

Loading locations...

相似试验